drugset / Trial / NCT01574131

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

NCT01574131

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to learn the following: whether long-term treatment (6 months) with fenofibrate will decrease burn related sugar and fat increased in the blood and help prevent muscle loss and improve wound healing.

Timeline

Start
2012-05
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule 54 mg
Comparator Fenofibrate Small molecule 160 mg

Indications

No indication recorded.